Imagine looking at a very young Ian McKellen, the knighted British actor, and thinking, “Half a century from now, if they ever film the Lord of the Rings trilogy, he could be the best Gandalf ever!” That kind of vision is rare – but scientist Neil Bander, M.D., has it. Nearly three decades ago, Bander, […]
Maybe you’ve been diagnosed with high-risk prostate cancer. Maybe you have already been treated for prostate cancer, but your PSA is starting to creep back up, which means that the treatment didn’t get all of the cancer – but maybe it’s just right there in the prostate area, easily targetable with radiation. Or maybe it’s […]
A full-on assault of high-risk prostate cancer with intensive neoadjuvant hormonal therapy before surgery marks a huge shift in medical thinking. Instead of doing things in a well-ordered sequence, oncologists like UCSD’s Rana McKay are launching many weapons earlier than ever, when cancer is less prepared for battle, and they’re going for a cure. Why […]
You have metastatic prostate cancer, and your doctor has said you’re doing all you can do. How can you be sure? This is a post that’s very close to my heart, because I have met many men over the years who hear this from their doctors and they just accept it. Maybe you truly are […]
We’ve talked about PSMA-PET before, but now it has gotten FDA approval for use in imaging prostate cancer. This is just the start: more approvals are expected. PSMA-targeting is also being used in Europe and Australia, and in clinical trials in the U.S., as a means of treating prostate cancer, not just showing where it’s […]
I recently had the privilege of interviewing Peter Frampton (yes, THAT Peter Frampton!) for Johns Hopkins Rheumatology’s LEAP Magazine, and two things really struck me: One, he is really a nice, decent guy. And two, what he has taught his doctors about muscle memory and retaining function through repeated practice and hard work has changed […]
This is an update to a story I wrote five years ago, for Johns Hopkins Rheumatology’s LEAP Magazine, with two world experts on PTLD: post-treatment Lyme disease. They have uncovered some promising clues as to why, for some people, Lyme disease doesn’t go away, and identified some new potential avenues of treatment. Some people get […]